微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 23.76% | -31.36% | -0.1% | 41/51 | 35.76% | 南华生物 | 68.03% | 行业排名> |
| 2024-06-30 | 23.78% | -36.01% | 15.36% | 41/51 | 35.89% | 百诚医药 | 68.75% | 行业排名> |
| 2024-03-31 | 20.61% | -42.44% | -33.24% | 42/51 | 35.75% | 百诚医药 | 68.19% | 行业排名> |
| 2023-12-31 | 30.88% | -16.27% | -10.79% | 37/51 | 38.13% | 药康生物 | 67.61% | 行业排名> |
| 2023-09-30 | 34.61% | -4.21% | -6.87% | 35/51 | 39.87% | 药康生物 | 69.14% | 行业排名> |
| 2023-06-30 | 37.16% | -1.65% | 3.77% | 34/51 | 39.77% | 药康生物 | 68.49% | 行业排名> |
| 2023-03-31 | 35.81% | 2% | -2.88% | 33/51 | 38.93% | 药康生物 | 69.3% | 行业排名> |
| 2022-12-31 | 36.87% | -4.69% | 2.05% | 36/51 | 40.1% | 药康生物 | 71.38% | 行业排名> |
| 2022-09-30 | 36.13% | -18.03% | -4.38% | 34/51 | 41.1% | 药康生物 | 73.27% | 行业排名> |
| 2022-06-30 | 37.79% | 6.57% | -2.33% | 33/51 | 39.96% | 药康生物 | 75.32% | 行业排名> |
| 2021-12-31 | 38.69% | -9.11% | 9.11% | 33/51 | 41.94% | 药康生物 | 76.7% | 行业排名> |
| 2021-06-30 | 35.46% | -26.47% | -16.7% | 36/51 | 42.6% | 药康生物 | 74.33% | 行业排名> |
| 2020-12-31 | 42.57% | 5.63% | -3.44% | 26/51 | 38.51% | 南华生物 | 84.53% | 行业排名> |
| 2020-09-30 | 44.08% | 2% | 9.39% | 17/51 | 37.76% | 南华生物 | 83.19% | 行业排名> |
| 2019-12-31 | 40.3% | -1.67% | -16.43% | 27/51 | 42.94% | 南华生物 | 83.9% | 行业排名> |
| 2019-06-30 | 48.22% | 12.5% | 17.67% | 11/51 | 45.09% | 成都先导 | 79.36% | 行业排名> |
| 2018-12-31 | 40.98% | 2% | -4.39% | 27/51 | 42.09% | 成都先导 | 75.92% | 行业排名> |
| 2018-06-30 | 42.86% | 2% | 2% | 18/51 | 43.98% | 南华生物 | 78.74% | 行业排名> |